Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 11 | 2022 | 60 | 3.460 |
Why?
|
| Myocytes, Cardiac | 5 | 2023 | 166 | 2.400 |
Why?
|
| Hydrogels | 4 | 2022 | 37 | 2.150 |
Why?
|
| Alginates | 3 | 2020 | 11 | 2.010 |
Why?
|
| Hyaluronic Acid | 6 | 2018 | 33 | 1.940 |
Why?
|
| Tunica Intima | 3 | 2015 | 19 | 1.260 |
Why?
|
| Saphenous Vein | 3 | 2015 | 23 | 1.240 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2018 | 62 | 1.230 |
Why?
|
| Myocardium | 2 | 2020 | 235 | 1.210 |
Why?
|
| Nanotubes, Carbon | 2 | 2019 | 79 | 1.160 |
Why?
|
| Stainless Steel | 2 | 2017 | 6 | 1.030 |
Why?
|
| Cell Differentiation | 4 | 2017 | 587 | 0.970 |
Why?
|
| Tissue Scaffolds | 3 | 2022 | 25 | 0.940 |
Why?
|
| Endothelial Cells | 4 | 2022 | 308 | 0.870 |
Why?
|
| Gelatin | 2 | 2022 | 15 | 0.840 |
Why?
|
| Organoids | 1 | 2022 | 22 | 0.840 |
Why?
|
| Hyperglycemia | 1 | 2023 | 55 | 0.820 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 59 | 0.820 |
Why?
|
| Oxygen | 2 | 2015 | 207 | 0.800 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2007 | 130 | 0.780 |
Why?
|
| Biocompatible Materials | 3 | 2019 | 76 | 0.770 |
Why?
|
| Collagen Type I | 1 | 2021 | 30 | 0.760 |
Why?
|
| Zinc Oxide | 1 | 2020 | 16 | 0.740 |
Why?
|
| Cell Proliferation | 9 | 2017 | 1198 | 0.730 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 34 | 0.700 |
Why?
|
| Wound Healing | 1 | 2020 | 70 | 0.700 |
Why?
|
| Cell Culture Techniques | 4 | 2015 | 142 | 0.680 |
Why?
|
| Ink | 1 | 2018 | 5 | 0.640 |
Why?
|
| Cell Adhesion | 3 | 2017 | 212 | 0.640 |
Why?
|
| Stem Cells | 1 | 2019 | 141 | 0.620 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 225 | 0.620 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2017 | 19 | 0.580 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2015 | 37 | 0.570 |
Why?
|
| Neurotoxins | 1 | 2017 | 57 | 0.560 |
Why?
|
| Graphite | 1 | 2017 | 51 | 0.540 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2007 | 86 | 0.540 |
Why?
|
| Collagen | 5 | 2021 | 172 | 0.540 |
Why?
|
| Nanoparticles | 1 | 2020 | 318 | 0.530 |
Why?
|
| Iron | 1 | 2017 | 225 | 0.500 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 461 | 0.500 |
Why?
|
| Arteries | 2 | 2015 | 65 | 0.480 |
Why?
|
| Semaphorin-3A | 1 | 2013 | 2 | 0.470 |
Why?
|
| Cell Line | 5 | 2021 | 1354 | 0.460 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 10 | 0.450 |
Why?
|
| Nerve Growth Factors | 1 | 2013 | 33 | 0.450 |
Why?
|
| Cell Survival | 4 | 2020 | 864 | 0.450 |
Why?
|
| Nerve Regeneration | 1 | 2013 | 40 | 0.440 |
Why?
|
| Axons | 1 | 2013 | 108 | 0.430 |
Why?
|
| Humans | 16 | 2023 | 37093 | 0.410 |
Why?
|
| Dopamine | 1 | 2013 | 245 | 0.390 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 19 | 0.380 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 409 | 0.370 |
Why?
|
| Serum | 1 | 2010 | 15 | 0.370 |
Why?
|
| Catalase | 1 | 2010 | 109 | 0.370 |
Why?
|
| Animals | 13 | 2021 | 15081 | 0.340 |
Why?
|
| Surface Properties | 4 | 2017 | 130 | 0.330 |
Why?
|
| Extracellular Matrix | 2 | 2006 | 115 | 0.320 |
Why?
|
| Hyperplasia | 3 | 2015 | 38 | 0.310 |
Why?
|
| Oligosaccharides | 1 | 2006 | 24 | 0.280 |
Why?
|
| Elastin | 1 | 2006 | 40 | 0.280 |
Why?
|
| Cells, Cultured | 5 | 2013 | 1518 | 0.280 |
Why?
|
| Neurons | 1 | 2013 | 1175 | 0.270 |
Why?
|
| Pressure | 2 | 2019 | 43 | 0.260 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 202 | 0.260 |
Why?
|
| Hela Cells | 2 | 2016 | 366 | 0.230 |
Why?
|
| Materials Testing | 3 | 2017 | 69 | 0.230 |
Why?
|
| Signal Transduction | 3 | 2023 | 1908 | 0.230 |
Why?
|
| Fibrosis | 2 | 2021 | 159 | 0.220 |
Why?
|
| Organogenesis | 1 | 2022 | 16 | 0.210 |
Why?
|
| Aldehydes | 2 | 2015 | 69 | 0.210 |
Why?
|
| Glycyrrhizic Acid | 1 | 2021 | 4 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2020 | 272 | 0.200 |
Why?
|
| Glucose | 1 | 2023 | 230 | 0.190 |
Why?
|
| Cardiotonic Agents | 1 | 2021 | 37 | 0.190 |
Why?
|
| Gels | 1 | 2021 | 42 | 0.190 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2021 | 142 | 0.190 |
Why?
|
| Longevity | 1 | 2022 | 147 | 0.180 |
Why?
|
| Electric Conductivity | 1 | 2019 | 51 | 0.180 |
Why?
|
| Rheology | 1 | 2019 | 25 | 0.170 |
Why?
|
| Spectrum Analysis | 1 | 2019 | 54 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 149 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2011 | 859 | 0.160 |
Why?
|
| Rats | 5 | 2021 | 3483 | 0.160 |
Why?
|
| Prospective Studies | 1 | 2022 | 1378 | 0.160 |
Why?
|
| Inflammation | 1 | 2023 | 618 | 0.160 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 23 | 0.150 |
Why?
|
| Mice | 4 | 2018 | 5913 | 0.150 |
Why?
|
| Swine | 1 | 2018 | 184 | 0.150 |
Why?
|
| Hardness | 1 | 2017 | 6 | 0.150 |
Why?
|
| Silanes | 1 | 2017 | 5 | 0.150 |
Why?
|
| Propylamines | 1 | 2017 | 6 | 0.150 |
Why?
|
| Elastic Modulus | 1 | 2017 | 17 | 0.150 |
Why?
|
| X-Ray Diffraction | 1 | 2017 | 57 | 0.140 |
Why?
|
| Hexuronic Acids | 1 | 2016 | 5 | 0.140 |
Why?
|
| Glucuronic Acid | 1 | 2016 | 5 | 0.140 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2017 | 68 | 0.140 |
Why?
|
| Porosity | 1 | 2016 | 32 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 161 | 0.140 |
Why?
|
| Flow Cytometry | 1 | 2017 | 399 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1618 | 0.130 |
Why?
|
| Membrane Fluidity | 1 | 2015 | 11 | 0.130 |
Why?
|
| 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 2015 | 2 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1371 | 0.130 |
Why?
|
| Peptides | 1 | 2018 | 320 | 0.130 |
Why?
|
| Phenotype | 1 | 2017 | 689 | 0.120 |
Why?
|
| Free Radical Scavengers | 1 | 2015 | 66 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 140 | 0.120 |
Why?
|
| Indoles | 2 | 2018 | 158 | 0.120 |
Why?
|
| Immobilized Proteins | 1 | 2013 | 1 | 0.120 |
Why?
|
| Growth Cones | 1 | 2013 | 12 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1039 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 935 | 0.110 |
Why?
|
| Chickens | 1 | 2013 | 133 | 0.110 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 50 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2011 | 167 | 0.100 |
Why?
|
| Amitrole | 1 | 2010 | 4 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 67 | 0.100 |
Why?
|
| DNA Primers | 1 | 2011 | 286 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2010 | 51 | 0.090 |
Why?
|
| Superoxides | 1 | 2010 | 53 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 103 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 90 | 0.090 |
Why?
|
| Partial Pressure | 1 | 2010 | 9 | 0.090 |
Why?
|
| Mitotic Index | 1 | 2010 | 9 | 0.090 |
Why?
|
| Perfusion | 1 | 2010 | 33 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 189 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2010 | 19 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 32 | 0.090 |
Why?
|
| Biomass | 1 | 2010 | 54 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 133 | 0.090 |
Why?
|
| Hydrogen | 1 | 2010 | 47 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2231 | 0.090 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 155 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 448 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 77 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 677 | 0.090 |
Why?
|
| Base Sequence | 1 | 2011 | 997 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 267 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 237 | 0.080 |
Why?
|
| Aorta | 2 | 2006 | 167 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2011 | 928 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 513 | 0.080 |
Why?
|
| Antioxidants | 1 | 2010 | 416 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 2 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 69 | 0.070 |
Why?
|
| Particle Size | 1 | 2006 | 215 | 0.060 |
Why?
|
| Ultraviolet Rays | 2 | 2018 | 117 | 0.050 |
Why?
|
| Rats, Zucker | 1 | 2021 | 23 | 0.050 |
Why?
|
| Troponin I | 1 | 2021 | 18 | 0.050 |
Why?
|
| Connexin 43 | 1 | 2021 | 38 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 95 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 69 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 77 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 197 | 0.040 |
Why?
|
| Fluorescence | 1 | 2018 | 121 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2018 | 308 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2006 | 22 | 0.020 |
Why?
|